Position in IDXX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$284,878
-$9,672,976 QoQ
Shares Held
507
-97.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026TWINBEECH CAPITAL LP holds $13,428,259 across 8 Diagnostics & Research names. IDXX ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
68,803 | $7,842,165 | |
| 2 | SHC |
Sotera Health Co
|
151,952 | $2,178,991 | |
| 3 | DHR |
Danaher Corp /De/
|
4,320 | $819,072 | |
| 4 | NEO |
Neogenomics Inc
|
106,300 | $788,746 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
|
54,277 | $753,364 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
8,000 | $513,760 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
This page
|
507 | $284,878 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,450 | $247,283 |
All Filings in IDXX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $284,878 | 507 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $9,957,854 | 23,712 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $21,119,145 | 43,348 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $55,900,572 | 103,533 | Shares | Sole | 2024-05-15 | |
| 2021-12-31 | $530,718 | 806 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $677,249 | 1,089 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $5,455,806 | 11,150 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $952,252 | 1,905 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||